Ranibizumab according to need: a treatment for age-related macular degeneration

Am J Ophthalmol. 2007 Apr;143(4):679-80. doi: 10.1016/j.ajo.2007.02.024.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Angiogenesis Inhibitors / administration & dosage*
  • Antibodies, Monoclonal / administration & dosage*
  • Antibodies, Monoclonal, Humanized
  • Choroidal Neovascularization / diagnosis
  • Choroidal Neovascularization / drug therapy*
  • Fluorescein Angiography
  • Humans
  • Injections
  • Macular Degeneration / diagnosis
  • Macular Degeneration / drug therapy*
  • Ranibizumab
  • Retreatment
  • Tomography, Optical Coherence*
  • Treatment Outcome
  • Visual Acuity
  • Vitreous Body

Substances

  • Angiogenesis Inhibitors
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Ranibizumab